All In MedTech

Device Trial Radar · NCT05686278

Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty

A Post-market Clinical Follow-up (PMCF) Study to Evaluate Clinical, Radiographic and Patient Reported Outcomes Following a Hip Hemiarthroplasty Surgery Using Corin Devices

Last checked: Nov 19, 2026Latest source record: Mar 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

368

Planned (sponsor's estimate)

Start

Jun 29, 2023

Primary completion

Sep 2028

Study completion Sep 2035

Sponsor

Lead sponsor
CorinNot on our public-company list
Sponsor type
Industry
First posted
Jan 17, 2023

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This PMCF study is designed to collect safety and efficacy data on hip hemiarthroplasty surgeries with Corin BiPolar-i shell and the Oceane+ or Meije Duo femoral stem up to 10 years.

Conditions

  • Hip Fractures
  • Hip Hemiarthroplasty
  • Osteoarthritis, Hip
  • Avascular Necrosis of Hip
  • Femoral Neck Fractures

Interventions

  • Bipolar i and cemented stem (Océane+ or Meije)Device

    Hip hemiarthroplasty is a surgical procedure that involves replacing half of the hip joint

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of safety of the study devices at 2 years after a hip hemiarthroplasty surgery.Time frame: 2 years

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Polyclinique Henin Beaumont

    Hénin-Beaumont, France · Terminated

  • Hopital Saint Joseph

    Paris, France · Recruiting

  • Hopital Diaconesses Croix Saint Simon

    Paris, France · Not yet recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.